MedPage Today on MSN
'Misleading' Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF
The SGLT2 inhibitor empagliflozin (Jardiance) showed some potential for heart failure (HF) prevention in high-risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback